Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

70.69
Delayed Data
As of 4:00pm ET
 -0.32 / -0.45%
Today’s Change
70.30
Today|||52-Week Range
103.10
-1.28%
Year-to-Date
Wendell David Associates Inc Buys CDK Global Inc, Dentsply Sirona Inc, Alphabet Inc, ...
11:44am / GuruFocus News - Paid Partner Content
3 Incredibly Cheap High-Yield Dividend Stocks
Jan 22 / MotleyFool.com - Paid Partner Content
Can Q4 Earnings Revitalize Healthcare ETFs?
11:40am / Zacks.com - Paid Partner Content
Jerome Dodson Adds to Gilead Sciences Position
Jan 20 / GuruFocus News - Paid Partner Content
Stock Market News for January 23, 2017
10:51am / Zacks.com - Paid Partner Content
Is Gilead Sciences (GILD) a Great Stock for Value Investors?
Jan 20 / Zacks.com - Paid Partner Content
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
9:47am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Wo...
Jan 20 / Zacks.com - Paid Partner Content
How Will Gilead Sciences Fare Under President Trump?
Jan 22 / MotleyFool.com - Paid Partner Content
Are You Undervaluing These 3 Biopharmas' Pipelines?
Jan 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close71.01
Today’s open70.87
Day’s range70.30 - 71.29
Volume9,607,302
Average volume (3 months)9,686,762
Market cap$93.6B
Dividend yield2.66%
Data as of 4:00pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-9.42%
Earnings growth (next 5 years)-0.55%
Revenue growth (last year)+28.71%
P/E ratio6.6
Price/Sales4.80
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.95-1.26%
BIIBBiogen-4.64-1.65%
ILMNIllumina Inc+1.15+0.72%
ARIAARIAD Pharmaceutical...-0.04-0.17%
Data as of 4:00pm ET, 01/23/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$2.61
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs